KLI
Login
OAK 국가리포지터리
검색
Community
Titles
Authors
Keyword
Issue Date
Ulsan Univ. Repository
Browsing by Author : Dong-Wan Kim
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Etal:
All
1
3
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 9 of 9
1
Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
김상위
;
Benjamin C Creelan
;
Don L Gibbons
;
et al
2021
2
Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
김상위
;
Benjamin C Creelan
;
Don L Gibbons
;
et al
2021
3
Article
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors
Byoung Chul Cho
;
Ji-Youn Han
;
Sang-We Kim
;
et al
2022
4
Article
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
김상위
;
Amy Roshak
;
Byoung Chul Cho
;
et al
2021
5
Article
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer
이대호
;
Adnan Nagrial
;
Byoung Chul Cho
;
et al
2021
6
Article
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer
Pasi A Jänne
;
Christina Baik
;
Wu-Chou Su
;
et al
2022
7
Article
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
이대호
;
Aaron S Mansfield
;
Benjamin Besse
;
et al
2021
8
Article
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
김상위
;
Bong-Seog Kim
;
Byoung Chul Cho
;
et al
2020
9
Article
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis
김상위
;
Byoung Chul Cho
;
Cheol Hyeon Kim
;
et al
2020
1
Anonymous
Login
Community
Titles
Authors
Keyword
Issue Date
Guide